Sling Therapeutics
Latest round
- Series C
Last raised
- Sep 2026
Total raised
- $158M
Investors
- 3
About Sling Therapeutics
Based in Michigan, US, and founded in 2020, Sling Therapeutics, Inc. operates as a biopharmaceutical firm specializing in thyroid eye disease's later stages of development. In September 2026, Sling Therapeutics, Inc. The firm offers Linsitinib, an oral small drug from Sling Therapeutics, which is in a Phase 2b study for thyroid eye disease (TED) and acts by blocking the confirmed IGF-1R target. Linsitinib has a proven safety profile after treating over 800 individuals and is being studied for the treatment of other autoimmune and uncommon disorders.
Who invested in Sling Therapeutics
3 investors across 2 rounds
See all investors in Sling Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Sling Therapeutics
Who invested in Sling Therapeutics?
Sling Therapeutics has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sling Therapeutics raised?
Sling Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Sling Therapeutics last raise money?
Sling Therapeutics's most recent round on record is a Series C, in Sep 2026.
What does Sling Therapeutics do?
Based in Michigan, US, and founded in 2020, Sling Therapeutics, Inc.
Where is Sling Therapeutics headquartered?
Sling Therapeutics is headquartered in Ann Arbor, US.
Which VCs invest in companies like Sling Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Sling Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Sling Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.